Competitive Problems in the Drug Industry : The Risks and Benefits of Oral Contraceptives.
CRS report, prepared by Vikki A. Zegel and Blanchard Randall IV for the Subcom on Monopoly and Anticompetitive Activities, reviewing major issues raised during 1970 subcom hearings to consider the safety of oral contraceptives.
| Corporate Authors: | , |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
1978.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | CRS report, prepared by Vikki A. Zegel and Blanchard Randall IV for the Subcom on Monopoly and Anticompetitive Activities, reviewing major issues raised during 1970 subcom hearings to consider the safety of oral contraceptives. Summarizes 1970 testimony (topical index, p. 64-67) and subsequent findings regarding the relationship of oral contraceptives to circulatory disorders, hypertension, cancer, liver disease, and other health problems. Also examines FDA regulation of oral contraceptives marketing and labeling. Appendices (p. 62-124) include: |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed June 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |